CXCR

CXCR(CXC 趋化因子受体)是特异性结合并响应 CXC 趋化因子家族细胞因子的整合膜蛋白。它们代表趋化因子受体的一个亚家族,即 G 蛋白连接受体的一个大家族,被称为七跨膜 (7-TM) 蛋白,因为它们跨越细胞膜七次。目前已知哺乳动物中有七种 CXC 趋化因子受体,分别命名为 CXCR1 至 CXCR7。CXCR1 和 CXCR2 是密切相关的受体,它们识别在其 CXC 基序紧邻处具有 ELR 氨基酸基序的 CXC 趋化因子。CXCR3 主要在 T 淋巴细胞上表达。CXCR4 是称为 CXCL12(或 SDF-1)的趋化因子的受体,与 CCR5 一样,被 HIV-1 用于进入靶细胞。趋化因子受体 CXCR5 在 B 细胞上选择性表达,参与淋巴细胞归巢和正常淋巴组织的发育。CXCR6 以前有三种不同的名称(STRL33、BONZO 和 TYMSTR),后来根据其染色体位置及其基因序列与其他趋化因子受体的相似性将其指定为 CXCR6。CXCR7 最初被称为 RDC-1(孤儿受体),但后来被证明会在 CXCL12(CXCR4 的配体)的作用下引起 T 淋巴细胞趋化,促使该分子重新命名为 CXCR7。

CXCRs (CXC chemokine receptors) are integral membrane proteins that specifically bind and respond to cytokines of the CXC chemokine family. They represent one subfamily of chemokine receptors, a large family of G protein-linked receptors that are known as seven transmembrane (7-TM) proteins, since they span thecell membrane seven times. There are currently seven known CXC chemokine receptors in mammals, named CXCR1 through CXCR7. CXCR1 and CXCR2 are closely related receptors that recognize CXC chemokines that possess an E-L-R amino acid motif immediately adjacent to their CXC motif. CXCR3 is expressed predominantly on T lymphocytes. CXCR4 is the receptor for a chemokine known as CXCL12 (or SDF-1) and, as with CCR5, is utilized by HIV-1 to gain entry into target cells. The chemokine receptor CXCR5 is selectively expressed on B cells and is involved in lymphocyte homing and the development of normal lymphoid tissue. CXCR6 was formerly called three different names (STRL33, BONZO, and TYMSTR) before being assigned CXCR6 based on its chromosomal location and its similarity to other chemokine receptors in its gene sequence. CXCR7 was originally called RDC-1 (an orphan receptor) but has since been shown to cause chemotaxis in T lymphocytes in response to CXCL12 (the ligand for CXCR4) prompting the renaming of this molecule as CXCR7.

共 100种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(±)-AMG 487

(±)-AMG 487 是 AMG 487 的外消旋体,而 AMG 487 是一种有效的、具有口服活性的选择性趋化因子受体3 (CXCR3) 拮抗剂,抑制 CXCL10 和 CXCL11 与 CXCR3 结合的 IC50 值分别为 8.0 和 8.2 nM。

947536-03-0
Inhibitor
(±)-AMG 487
4-Amino-D-phenylalanine
4-NH2-d-Phe

4-Amino-D-phenylalanine([D-Phe(4-NH2)])是一种环状五肽,可抑制CXCL12与FC131中CXCR4的结合,其IC50值为0.1 μM。

102281-45-8
Inhibitor
99.74%
4-Amino-D-phenylalanine
ALX 40-4C

ALX 40-4C 是一种趋化因子受体 (CXCR4) 抑制剂,可抑制 SDF-1 与 CXCR4 的结合(Ki 值为 1 μM),具有抗 HIV-1 作用,而 ALX 40-4C Trifluoroacetate 同时也是 APJ 受体拮抗剂(IC50 值为 2.9 μM)。

143413-49-4
Inhibitor
ALX 40-4C
ALX 40-4C Trifluoroacetate

ALX 40-4C Trifluoroacetate 是一种趋化因子受体 (CXCR4) 抑制剂,可通过抑制 SDF-1 与 CXCR4 结合发挥抗 HIV-1 作用,其 Ki 值为 1 μM,同时它也是 APJ 受体拮抗剂,IC50 值为 2.9 μM。

Inhibitor
99.78%
ALX 40-4C Trifluoroacetate
ALX-0651

ALX-0651 是一种靶向 CXCR4 的双互补位人源化单克隆抗体抑制剂,可抑制造血干细胞运输以及肿瘤进展和转移,可用于非霍奇金淋巴瘤和多发性骨髓瘤研究。

Inhibitor
ALX-0651
AMD 3329 octahydrobromide

AMD 3329 octahydrobromide是一种强效且选择性的抗HIV-1和HIV-2化合物,通过结合化学趋化因子受体CXCR4阻止病毒入侵,从而抑制病毒复制,其抑制HIV-1和HIV-2复制的EC50值分别低至0.8和1.6 nM,抗病毒效果优于AMD3100,并能显著抑制特定CXCR4单克隆抗体的结合及SDF-1alpha诱导的Ca(2+)通量,还可有效干扰病毒诱导的合胞体形成(EC50值为12 nM)。

170861-77-5
Inhibitor
AMD 3329 octahydrobromide
AMD-3329

AMD-3329 是一种强效且选择性的抗 HIV-1 和 HIV-2 化合物,通过与 X4 病毒进入所需的辅助受体趋化因子受体 CXCR4 结合并抑制病毒复制而发挥活性。

170861-87-7
Inhibitor
AMD-3329
AMG 487

AMG 487 是一种有效的、具有口服活性和选择性的趋化因子受体3 (CXCR3) 拮抗剂,抑制 CXCL10 和 CXCL11 与 CXCR3 结合的 IC50 值分别为 8.0 和 8.2 nM。

473719-41-4
Inhibitor
99.89%
AMG 487
Anti-CD185/CXCR5 Antibody
BAY-924 antibody

Anti-CD185/CXCR5 Antibody 是一种靶向人 CD185/CXCR5 的抗体抑制剂。

Inhibitor
97.41%
Anti-CD185/CXCR5 Antibody
Anti-CXCR2 Antibody

Anti-CXCR2 Antibody 是一种抗 CXCR2 抗体,推荐的同型对照为 Human IgG1 kappa, Isotype Control (MS-E04981)。

Inhibitor
Anti-CXCR2 Antibody
Anti-CXCR3 Antibody (5H7)

Anti-CXCR3 Antibody (5H7) 是一种以 CXCR3 为抗原产生的小鼠单克隆抗体,推荐的同型对照为人 IgG1 kappa, Isotype Control,同型对照 (MS-E04981)。

Inhibitor
Anti-CXCR3 Antibody (5H7)
Anti-Human/Monkey CXCR4 Antibody (12G5)

Anti-Human/Monkey CXCR4 Antibody (12G5) 可与人及猴 CXCR4 反应,并可阻断其配体 CXCL12/SDF-1 和 gp120/160 与 CXCR4 的结合,推荐的同型对照为 Mouse IgG2a kappa, Isotype Control (MS-H97358)。

Inhibitor
Anti-Human/Monkey CXCR4 Antibody (12G5)

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础